Du F - Search Results

1

[Neuroendocrine tumors: analysis of 252 cases].

Chi YH, Jiang WC, Du F, Sun YK, Song Y, Yang L, Zhou AP, Wang JW. Chi YH, et al. Among authors: du f. Zhonghua Zhong Liu Za Zhi. 2013 Jan;35(1):67-70. doi: 10.3760/cma.j.issn.0253-3766.2013.01.015. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23648305 Chinese.

2

[Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].

Qin Q, Yang L, Zhou AP, Sun YK, Song Y, DU F, Wang JW. Qin Q, et al. Among authors: du f. Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):212-6. doi: 10.3760/cma.j.issn.0253-3766.2013.03.011. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23880003 Chinese.

3

Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.

Chi Y, Du F, Zhao H, Wang JW, Cai JQ. Chi Y, et al. Among authors: du f. World J Gastroenterol. 2014 Nov 21;20(43):16252-7. doi: 10.3748/wjg.v20.i43.16252. World J Gastroenterol. 2014. PMID: 25473180 Free PMC article.

4

S-1 and Cisplatin With or Without Nimotuzumab for Patients With Untreated Unresectable or Metastatic Gastric Cancer: A Randomized, Open-Label Phase 2 Trial.

Du F, Zheng Z, Shi S, Jiang Z, Qu T, Yuan X, Sun Y, Song Y, Yang L, Zhao J, Wang J, Chi Y. Du F, et al. Medicine (Baltimore). 2015 Jun;94(23):e958. doi: 10.1097/MD.0000000000000958. Medicine (Baltimore). 2015. PMID: 26061330 Free PMC article. Clinical Trial.

5

Diagnosis, treatment, and prognosis of bronchopulmonary carcinoid: an analysis of 74 patients.

Chi Y, Gao S, Du F, Wang JW, Jiang WC, Sun YK, Song Y, He J. Chi Y, et al. Among authors: du f. Anticancer Drugs. 2016 Jan;27(1):54-9. doi: 10.1097/CAD.0000000000000292. Anticancer Drugs. 2016. PMID: 26398932

6

Clinicopathological Characteristics and Prognosis of Colorectal Cancer in Chinese Adolescent Patients.

Du F, Shi SS, Sun YK, Wang JW, Chi Y. Du F, et al. Chin Med J (Engl). 2015 Dec 5;128(23):3149-52. doi: 10.4103/0366-6999.170256. Chin Med J (Engl). 2015. PMID: 26612287 Free PMC article.

7

[Efficacy and toxicity of vinorelbine (NVB)-based regimens in patients with metastatic triple negative breast cancer (mTNBC) pretreated with anthracyclines and taxanes].

Du F, Yuan P, Luo Y, Wang J, Ma F, Cai R, Fan Y, Li Q, Zhang P, Xu B. Du F, et al. Zhonghua Zhong Liu Za Zhi. 2015 Oct;37(10):788-92. Zhonghua Zhong Liu Za Zhi. 2015. PMID: 26813602 Chinese.

8

Cardia and Non-Cardia Gastric Cancer Have Similar Stage-for-Stage Prognoses After R0 Resection: a Large-Scale, Multicenter Study in China.

Zhao J, Zhao J, Du F, Zhang Y, Shen G, Zhu H, Ji F, Ma F, Dong L, Kan J, Zheng F, Chen H, Wang Z, Xu B. Zhao J, et al. Among authors: du f. J Gastrointest Surg. 2016 Apr;20(4):700-7. doi: 10.1007/s11605-016-3089-z. Epub 2016 Feb 1. J Gastrointest Surg. 2016. PMID: 26831062

9

Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative, metastatic breast cancer.

Chen XL, Du F, Hong RX, Wang JY, Luo Y, Li Q, Fan Y, Xu BH. Chen XL, et al. Among authors: du f. Chin J Cancer. 2016 Apr 25;35:39. doi: 10.1186/s40880-016-0101-7. Chin J Cancer. 2016. PMID: 27112139 Free PMC article.

10

A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment.

Du F, Yuan P, Zhao ZT, Yang Z, Wang T, Zhao JD, Luo Y, Ma F, Wang JY, Fan Y, Cai RG, Zhang P, Li Q, Song YM, Xu BH. Du F, et al. Sci Rep. 2016 Sep 21;6:33825. doi: 10.1038/srep33825. Sci Rep. 2016. PMID: 27650797 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,774 results

Search Page

Filters